Patient info Open main menu

K/L Poultice (Kaolin Poultice BP) – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Not available Details

The Summary of Product Characteristics (SmPC) is written for healthcare professionals. Patients will find plain advice in the patient information leaflet.

Medicine strength:
200 mg/ml
Contains active substance:
ATC code:

Summary of Product Characteristics (SmPC) - K/L Poultice (Kaolin Poultice BP)

1 NAME OF THE MEDICINAL PRODUCT

KAOLIN POULTICE BP

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Name of Ingredient Quantity (per kg)

Heavy Kaolin 527.0g Thymol 0.5g Boric Acid 45.0g Peppermint Oil 0.5g Methyl Salicylate 2.0ml

All ingredients are of BP quality

3 PHARMACEUTICAL FORM

Poultice.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

Reduces inflammation and alleviates pain.

4.2 Posology and method of administration

Method of administration External application to the affected area.

Posology External poultice applied on a foil backing or directly.

Adults, elderly and children To be used on adults only.

4.3 Contraindications

Known hypersensitivity to salicylates or any other ingredients.

4.4 Special warnings and precautions for use

To be applied on unbroken skin of adults only. Test heat of poultice before use.

For external use only.

Keep out of the reach of children.

Close container when not in use.

For use on adults only (including the elderly). Not to be used on infants and children.

Not to be used on broken skin

4.5 Interaction with other medicinal products and other forms of interaction

No significant clinical interactions known.

4.6 Fertility, pregnancy and lactation

As with all medicines, avoid in pregnancy and breast feeding, unless advised by a medical practitioner.

4.7 Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

Rarely hypersensitivity reactions can occur.

4.9 Overdose

Should accidental ingestion occur, treat symptomatically.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Topical application of the ingredients of the poultice help to alleviate pain and reduce inflammation.

5.2 Pharmacokinetic properties

The amount of Salicylate included in the product is small and therefore unlikely to cause any significant hazard.

5.3 Preclinical safety data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Glycerol

6.2 Incompatibilities

None known.

6.3 Shelf life

3 years.

6.4 Special precautions for storage

None.

6.5 Nature and contents of container

Polypropylene tub containing 200, 500 or 1000g. Laminated foil pouch containing 100g.

6.6 Special precautions for disposal

Pouches

1 Heat the poultice in boiling water for not more than 40 seconds. 2 Remove from the boiling water.

3 Place pouch on a flat surface and cut around edges with scissors. 4 Remove clear cover.

5 Test heat before use.

6 Apply to the affected area and bandage in place.

Jars

1 Loosen lid of jar. Heat in hot water until contents are hot. 2 Do not bring jar into contact with direct heat by any other means. 3 Stir thoroughly.

4 Spread thickly on lint or a suitable alternative. 5 Test heat before use.

6 Apply to affected area. Bandage lightly.

7 Leave in place for 12 to 24 hours as directed by medical advice.

7 MARKETING AUTHORISATION HOLDER

KL Pharmaceutical Limited

21 Macadam Place

South Newmoor

Irivine

Ayrshire

KA11 4HP

8 MARKETING AUTHORISATION NUMBER(S)

PL 03436/0001

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

02/11/2005

10 DATE OF REVISION OF THE TEXT

02/11/2005

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 03436/0001

Last revision stated in the text: 2 November 2005 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about K/L Poultice (Kaolin Poultice BP)

Active substance Kaolin
Strength 200 mg/ml
Pharmaceutical form Oral suspension
How is it taken Oral
Excipients Glycerol
Is it available? No, it is listed as not available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage None.
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents
      1. A07B Intestinal adsorbents
        1. A07BC Other intestinal adsorbents
          1. A07BC02 kaolin
Marketing authorisation PL 03436/0001 (first authorised 2 November 2005)
Marketing authorisation holder KL Pharmaceutical Limited
Codes BNF 01040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.